HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Estee Lauder Sharpens Its Focus On Evolving U.S. Customer Base

This article was originally published in The Rose Sheet

Executive Summary

Beauty giant zeroes in on North America “on a granular level,” with the goal of better understanding the needs of diverse demographics and targeting product innovations accordingly. Lauder’s net sales for the fiscal 2014 second quarter grew 3% to $3.02 billion.

You may also be interested in...



Firms Face New Retail Challenges In Post-Recession Climate – RILA Exec

Retail Industry Leaders Association exec Lisa LaBruno outlines challenges faced by manufacturers and their retail partners in the wake of the recession, including sustainability targets and changed shopping behavior among consumers.

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

Guidance Opening Sanitizer Production Stirs Firms Including Anheuser-Busch, Dow, Kodak

Dow Chemical, Anheuser-Busch and Kodak designate manufacturing for hand sanitizers and donate products to fight COVID-19. Dow is making up to 15 tons of sanitizer a day while Kodak donates formulas to New York's “NYS Clean” sanitizer distribution program.

UsernamePublicRestriction

Register

RS019349

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel